Combination of the histone deacetylase inhibitor LBH589 and the hsp90 inhibitor 17-AAG is highly active against human CML-BC cells and AML cells with activating mutation of FLT-3.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples